Johan Dalen
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Prevalence of axial spondyloarthritis (axSpA) in patients treated for chronic back pain in chiropractic clinics: the oregon chiropractic axial spondyloarthritis study (ORCAS).
Journal: Clinical rheumatology
Published: April 08, 2025
First-line sunitinib treatment modification in patients with mRCC: nationwide analysis of the Swedish population.
Journal: Future oncology (London, England)
Published: October 28, 2024
Real-world experience of second-line axitinib in metastatic renal cell carcinoma: analysis of the Swedish population.
Journal: Future oncology (London, England)
Published: July 26, 2024
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication.
Journal: Advances in therapy
Published: April 14, 2023
Treatment patterns for advanced non-small cell lung cancer in the US: A systematic review of observational studies.
Journal: Cancer treatment and research communications
Published: June 28, 2022
Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study.
Journal: Advances in therapy
Published: March 03, 2022
Correction to: Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study.
Journal: Advances in therapy
Published: November 08, 2021
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study.
Journal: Advances in therapy
Published: August 30, 2021
Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study.
Journal: Advances in therapy
Published: June 01, 2021
Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study.
Journal: Advances in therapy
Published: June 01, 2020
Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis - A Systematic Literature Review.
Journal: Patient preference and adherence
Published: November 16, 2019
Last Updated: 09/26/2026